BiotechTube
Home/Cycuria Therapeutics/John Haurum
JH

John Haurum

Corporate Advisor

Cycuria Therapeutics

Therapeutic Areas

OncologyHematological MalignanciesAcute Myeloid Leukemia (AML)

Cycuria Therapeutics Pipeline

DrugIndicationPhase
Lymphotoxin-alpha-based therapyAcute Myeloid Leukemia (AML)Pre-clinical

Leadership Team at Cycuria Therapeutics

DN
Dr. Nisit Khandelwal
Co-Founder & CEO
PD
Prof. Dr. Philipp J. Jost
Inventor & Co-Founder
PD
Prof. Dr. Felix Wieland
Scientific Advisor
View full Cycuria Therapeutics profile